Literature DB >> 25773063

CD4 T Cells but Not Th17 Cells Are Required for Mouse Lung Transplant Obliterative Bronchiolitis.

Qiang Wu1, Pawan Kumar Gupta1, Hidemi Suzuki2, Sarah R Wagner1, Chen Zhang3, Oscar W Cummings3, Lin Fan1, Mark H Kaplan4, David S Wilkes2, Rebecca A Shilling1.   

Abstract

Lung transplant survival is limited by obliterative bronchiolitis (OB), but the mechanisms of OB development are unknown. Previous studies in a mouse model of orthotopic lung transplantation suggested a requirement for IL-17. We have used this orthotopic mouse model to investigate the source of IL-17A and the requirement for T cells producing IL-17A. The major sources of IL-17A were CD4(+) T cells and γδ T cells. Depletion of CD4(+) T cells led to a significantly decreased frequency and number of IL-17A(+) lymphocytes and was sufficient to prevent acute rejection and OB. However, mice with STAT3-deficient T cells, which are unable to differentiate into Th17 cells, rejected lung allografts and developed OB similar to control mice. The frequency of IL-17A(+) cells was not decreased in mice with STAT3-deficient T cells due mainly to the presence of IL-17A(+) γδ T cells. Deficiency of γδ T cells also did not affect the development of airway fibrosis. Our data suggest that CD4(+) T cells are required for OB development and expansion of IL-17A responses in the lung, while Th17 and γδ T cells are not absolutely required and may compensate for each other. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell; animal models: murine; basic (laboratory) research/science; biology; bronchiolitis obliterans (BOS); immunobiology; lung (allograft) function/dysfunction; lung transplantation/pulmonology

Mesh:

Substances:

Year:  2015        PMID: 25773063      PMCID: PMC4679154          DOI: 10.1111/ajt.13215

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  34 in total

Review 1.  Role of Th17 cells and IL-17 in lung transplant rejection.

Authors:  Rebecca A Shilling; David S Wilkes
Journal:  Semin Immunopathol       Date:  2011-02-01       Impact factor: 9.623

2.  In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells.

Authors:  Christian Koenecke; Vijaykumar Chennupati; Susanne Schmitz; Bernard Malissen; Reinhold Förster; Immo Prinz
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

3.  In pursuit of new experimental models of obliterative bronchiolitis.

Authors:  D Kreisel; A E Gelman; S M Palmer
Journal:  Am J Transplant       Date:  2011-03-30       Impact factor: 8.086

4.  STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.

Authors:  Vedran Radojcic; Maria A Pletneva; Hung-Rong Yen; Sanja Ivcevic; Angela Panoskaltsis-Mortari; Anita C Gilliam; Charles G Drake; Bruce R Blazar; Leo Luznik
Journal:  J Immunol       Date:  2009-12-07       Impact factor: 5.422

5.  Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation.

Authors:  L Fan; H L Benson; R Vittal; E A Mickler; R Presson; A Jo Fisher; O W Cummings; K M Heidler; M R Keller; W J Burlingham; D S Wilkes
Journal:  Am J Transplant       Date:  2011-04-19       Impact factor: 8.086

6.  IL-17 contributes to the development of chronic rejection in a murine heart transplant model.

Authors:  Satoshi Itoh; Susumu Nakae; Robert C Axtell; Jeffrey B Velotta; Naoyuki Kimura; Naoki Kajiwara; Yoichiro Iwakura; Hirohisa Saito; Hideo Adachi; Lawrence Steinman; Robert C Robbins; Michael P Fischbein
Journal:  J Clin Immunol       Date:  2010-02-04       Impact factor: 8.317

Review 7.  Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond.

Authors:  R A Shilling; D S Wilkes
Journal:  Am J Transplant       Date:  2009-06-10       Impact factor: 8.086

8.  The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation.

Authors:  B M Vanaudenaerde; S I De Vleeschauwer; R Vos; I Meyts; D M Bullens; V Reynders; W A Wuyts; D E Van Raemdonck; L J Dupont; G M Verleden
Journal:  Am J Transplant       Date:  2008-09       Impact factor: 8.086

9.  Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.

Authors:  Xuebin Liu; Yun Sang Lee; Cheng-Rong Yu; Charles E Egwuagu
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

10.  T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt.

Authors:  Vanja Lazarevic; Xi Chen; Jae-Hyuck Shim; Eun-Sook Hwang; Eunjung Jang; Alexandra N Bolm; Mohamed Oukka; Vijay K Kuchroo; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2010-12-12       Impact factor: 25.606

View more
  14 in total

1.  Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet-/- Mouse Lung Allograft Recipients.

Authors:  E A Lendermon; J M Dodd-O; T A Coon; X Wang; C R Ensor; N Cardenes; C L Koodray; H L Heusey; M F Bennewitz; P Sundd; G C Bullock; I Popescu; L Guo; C P O'Donnell; M Rojas; J F McDyer
Journal:  Transplant Proc       Date:  2018-03-09       Impact factor: 1.066

2.  Gut Microbiota Can Impact Chronic Murine Lung Allograft Rejection.

Authors:  Qiang Wu; Benjamin Turturice; Sarah Wagner; Yue Huang; Pawan Kumar Gupta; Cody Schott; Ahmed Metwally; Ravi Ranjan; David Perkins; Maria-Luisa Alegre; Patricia Finn; G R Scott Budinger; Rebecca Shilling; Ankit Bharat
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

3.  Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.

Authors:  Lynn D Haynes; Walker A Julliard; Joshua D Mezrich; Glen Leverson; Keith C Meyer; William J Burlingham
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

4.  Mechanisms of Graft Rejection and Immune Regulation after Lung Transplant.

Authors:  Jason M Gauthier; Wenjun Li; Hsi-Min Hsiao; Tsuyoshi Takahashi; Saeed Arefanian; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 5.  Mechanisms of graft rejection after lung transplantation.

Authors:  Hsi-Min Hsiao; Davide Scozzi; Jason M Gauthier; Daniel Kreisel
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

6.  IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.

Authors:  Pawan Kumar Gupta; Sarah R Wagner; Qiang Wu; Rebecca A Shilling
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

7.  Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.

Authors:  J A Sullivan; E Jankowska-Gan; S Hegde; M A Pestrak; V V Agashe; A C Park; M E Brown; J F Kernien; D S Wilkes; D B Kaufman; D S Greenspan; W J Burlingham
Journal:  Am J Transplant       Date:  2016-12-19       Impact factor: 8.086

Review 8.  IL-17 in the lung: the good, the bad, and the ugly.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

9.  Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation.

Authors:  Oliver McCallion; Joanna Hester; Fadi Issa
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

10.  Th17 cells are not required for maintenance of IL-17A-producing γδ T cells in vivo.

Authors:  Pawan K Gupta; Sarah R Wagner; Qiang Wu; Rebecca A Shilling
Journal:  Immunol Cell Biol       Date:  2016-09-21       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.